Ledger.Open graph →
SEC Form D · filed December 2, 2024

Aletheia BioTherapeutics, LLC

Offering
$7.4M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

G. Haslett · New York, NYExec · DirectorThomas Barton · New York, NYDirectorMichael Muhonen · New York, NYDirectorLaurie Platek · New York, NYExec · DirectorChrystyna Bedrij · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗